Imodium

Loperamide Hydrochloride, the active ingredient in Imodium, is a opioid receptor agonist (peripheral) presented as an unknown strength/form for oral use. It treats acute nonspecific diarrhea, chronic diarrhea and irritable bowel syndrome with diarrhea in adults.

GNH USA supplies Imodium as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium acts on the gastrointestinal tract to reduce excessive bowel movements associated with diarrheal disorders. - Acute nonspecific diarrhea: reduces stool frequency and improves consistency. - Chronic diarrhea: helps control ongoing loose stools and reduces urgency. - Irritable bowel syndrome with diarrhea: alleviates diarrhea‑predominant IBS symptoms.

Loperamide may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Constipation: hard or infrequent stools. - Nausea: mild stomach upset. - Abdominal cramps: intermittent discomfort. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Paralytic ileus: severe bowel obstruction. - Cardiac arrhythmias: abnormal heart rhythm. - Severe allergic reaction: rash, swelling, difficulty breathing.

Before using Imodium, consider the following safety measures. - Use only as directed: follow prescriber instructions for duration and dosage. - Assess hydration status: ensure adequate fluid intake to prevent dehydration. - Avoid use in children under 2 years: not recommended for very young patients. - Monitor for constipation: discontinue if severe constipation develops. - Do not combine with other antidiarrheals: may increase risk of adverse effects. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Loperamide can interact with several medicines; awareness helps prevent complications.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels. - P‑glycoprotein inhibitors (e.g., quinidine, ritonavir): can raise systemic exposure. - Other opioids: additive central effects, though loperamide is peripherally acting.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may enhance constipation. - Antidiarrheal agents (e.g., bismuth subsalicylate): overlapping mechanisms. - Sedatives or CNS depressants: monitor for increased drowsiness.